Achieve Life Sciences ACHV
NASDAQ ACHV
$7.69 -0.06 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) Research & Development (2010 - 2026)

Updated

Achieve Life Sciences' Research & Development came in at $3.39 million for Q2 2026, down 49.5% from $6.71 million a year earlier but up 13.9% from the prior quarter.

Analysis

Achieve Life Sciences (ACHV) Research & Development (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Achieve Life Sciences reported Research & Development of $15.53 million, down 45.9% year-over-year; for FY2025, it was $22.96 million, up 0.6% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of 27.3% (FY2020 to FY2025).
  • Going back by year, Research & Development was $22.82 million in FY2024 (+44.3%), $15.81 million in FY2023 (-47.4%), $30.08 million in FY2022 (+25.5%) and $23.97 million in FY2021 (+248.2%).
  • The five-year range for quarterly Research & Development is $2.11 million (Q4 2023) to $9.87 million (Q3 2022).
  • Year-over-year, Research & Development has declined for four consecutive quarters, with growth averaging 44.7% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2024 (growth of 245.1%), and the weakest in Q4 2023 (a decline of 75.5%).
  • Business Quant data shows ACHV's Research & Development at $2.98 million (Q1 2026), $3.84 million (Q4 2025) and $5.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Achieve Life Sciences 337.86 Mn 337.86 Mn - 3.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.39 Mn
Mar 31, 2026 2.98 Mn
Dec 31, 2025 3.84 Mn
Sep 30, 2025 5.32 Mn
Jun 30, 2025 6.71 Mn
Mar 31, 2025 7.10 Mn
Dec 31, 2024 7.30 Mn
Sep 30, 2024 7.61 Mn
Jun 30, 2024 5.11 Mn
Mar 31, 2024 2.80 Mn
Dec 31, 2023 2.11 Mn
Sep 30, 2023 3.58 Mn
Jun 30, 2023 4.59 Mn
Mar 31, 2023 5.53 Mn
Dec 31, 2022 8.61 Mn
Sep 30, 2022 9.87 Mn
Jun 30, 2022 7.21 Mn
Mar 31, 2022 4.39 Mn
Dec 31, 2021 4.51 Mn
Sep 30, 2021 4.59 Mn
API Access

Achieve Life Sciences Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ACHV&period=max&api_key=YOUR_API_KEY